{
  "batch": "157-sti-testing-and-co-performer-standard",
  "articles": [
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_panel_composition",
      "category": "Safety",
      "title": "[Unverified - being checked] Which tests the standard PASS panel requires",
      "summary": "[Unverified - being checked] The PASS standard panel clears to work on tests for seven STIs - HIV, hepatitis B, hepatitis C, syphilis, trichomoniasis, gonorrhea and chlamydia - while mycoplasma genitalium (Mgen) is listed only as a 30-day clearance and not part of the standard panel; gonorrhea and chlamydia require three-site clearance and HIV requires two methods.",
      "body": "The PASS standard panel clears to work on tests for seven STIs - HIV, hepatitis B, hepatitis C, syphilis, trichomoniasis, gonorrhea and chlamydia - while mycoplasma genitalium (Mgen) is listed only as a 30-day clearance and not part of the standard panel; gonorrhea and chlamydia require three-site clearance and HIV requires two methods.\n\nWhat PASS / Performer Availability Screening Service, Inc. actually says:\n\n“A complete non-reactive PASS STI testing panel clears participants to work for 14-days from the date of the specimen draw. All PASS partner testing facilities use this standard panel. HIV (Human Immunodeficiency Virus): HIV-1 RNA Qualitative PCR or HIV-1 RNA Quantitative PCR; HIV 1/2, 4th Gen AB/AG (Plasma or Serum). Hepatitis B (HBV): Hepatitis B Surface Antigen (Plasma or Serum). Hepatitis C (HCV): Anti-Hepatitis C (Plasma or Serum). Syphilis (Treponema pallidum): Reverse Testing Algorithm; RPR (reflex from reactive TPA acceptable) (Plasma or Serum). Trichomoniasis vaginalis: Aptima Trichomonas vaginalis Assay (or equivalent) (Urine / Swab). Gonorrhea (Neisseria gonorrhoeae): Aptima Combo 2 Assay (or equivalent); 3-site clearance: genital, pharyngeal, rectal (Urine / Swab). Chlamydia (Chlamydia trachomatis): Aptima Combo 2 Assay (or equivalent); 3-site clearance: genital, pharyngeal, rectal (Urine / Swab). Mgen (Mycoplasma genitalium): Clearance only required every 30 days, this is not part of the standard panel; FDA Approved NAAT PCR (Urine / Swab).”",
      "source_type": "official",
      "source_link": "https://www.passcertified.org/pass-database/pass-protocol",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "PASS / Performer Availability Screening Service, Inc.",
      "evidence_quote": "A complete non-reactive PASS STI testing panel clears participants to work for 14-days from the date of the specimen draw. All PASS partner testing facilities use this standard panel. HIV (Human Immunodeficiency Virus): HIV-1 RNA Qualitative PCR or HIV-1 RNA Quantitative PCR; HIV 1/2, 4th Gen AB/AG (Plasma or Serum). Hepatitis B (HBV): Hepatitis B Surface Antigen (Plasma or Serum). Hepatitis C (HCV): Anti-Hepatitis C (Plasma or Serum). Syphilis (Treponema pallidum): Reverse Testing Algorithm; RPR (reflex from reactive TPA acceptable) (Plasma or Serum). Trichomoniasis vaginalis: Aptima Trichomonas vaginalis Assay (or equivalent) (Urine / Swab). Gonorrhea (Neisseria gonorrhoeae): Aptima Combo 2 Assay (or equivalent); 3-site clearance: genital, pharyngeal, rectal (Urine / Swab). Chlamydia (Chlamydia trachomatis): Aptima Combo 2 Assay (or equivalent); 3-site clearance: genital, pharyngeal, rectal (Urine / Swab). Mgen (Mycoplasma genitalium): Clearance only required every 30 days, this is not part of the standard panel; FDA Approved NAAT PCR (Urine / Swab).",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS (Performer Availability Screening Services)",
      "topic": "Which tests the standard PASS panel requires",
      "applies_to_country": "US",
      "applies_to_scope": "Self-regulatory industry standard; PASS reports testing partners operating in the US and Canada. Trade body (non-profit ",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_panel_mgen",
      "category": "Safety",
      "title": "[Unverified - being checked] PASS (Performer Availability Screening Services): Mgen status in the standard panel",
      "summary": "[Unverified - being checked] Mgen clearance is required only once every 30 days and is not part of the standard 14-day PASS panel.",
      "body": "Mgen clearance is required only once every 30 days and is not part of the standard 14-day PASS panel.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“Mgen (Mycoplasma genitalium)* However, this is only required once every 30 days.”\n\nNote: Also on PASS protocol page: \"Clearance only required every 30 days, this is not part of the standard panel\".",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/pass",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "Mgen (Mycoplasma genitalium)* However, this is only required once every 30 days.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS (Performer Availability Screening Services)",
      "topic": "Mgen status in the standard panel",
      "applies_to_country": "US",
      "applies_to_scope": "Both FSC and PASS pages state the 30-day Mgen interval.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_panel_validity",
      "category": "Safety",
      "title": "[Unverified - being checked] Length of PASS clearance and how it is counted",
      "summary": "[Unverified - being checked] A complete non-reactive PASS panel clears a participant to work for 14 days, counted from the date of the specimen draw.",
      "body": "A complete non-reactive PASS panel clears a participant to work for 14 days, counted from the date of the specimen draw.\n\nWhat PASS / Performer Availability Screening Service, Inc. actually says:\n\n“A complete non-reactive PASS STI testing panel clears participants to work for 14-days from the date of the specimen draw.”\n\nNote: Clearance is a binary work-availability status, not a claim of disease-free status. FSC states it the same way: \"Clearance is given for 14 days from the date of when you go to get tested\".",
      "source_type": "official",
      "source_link": "https://www.passcertified.org/pass-database/pass-protocol",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "PASS / Performer Availability Screening Service, Inc.",
      "evidence_quote": "A complete non-reactive PASS STI testing panel clears participants to work for 14-days from the date of the specimen draw.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS (Performer Availability Screening Services)",
      "topic": "Length of PASS clearance and how it is counted",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_results_turnaround",
      "category": "Safety",
      "title": "[Unverified - being checked] PASS (Performer Availability Screening Services): Result turnaround time",
      "summary": "[Unverified - being checked] PASS testing results are typically expected within 48 hours from sample collection.",
      "body": "PASS testing results are typically expected within 48 hours from sample collection.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“Testing results are typically expected within 48 hours from sample collection”",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/pass",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "Testing results are typically expected within 48 hours from sample collection",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS (Performer Availability Screening Services)",
      "topic": "Result turnaround time",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_database_binary",
      "category": "Safety",
      "title": "[Unverified - being checked] What the PASS database stores",
      "summary": "[Unverified - being checked] The PASS database stores only a binary yes/no work-clearance determination made by the testing partner's clinical staff; no individual test results are uploaded to PASS.",
      "body": "The PASS database stores only a binary yes/no work-clearance determination made by the testing partner's clinical staff; no individual test results are uploaded to PASS.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“The PASS database only stores binary yes/no ‘work clearance’ data - meaning no individual test results are uploaded to PASS. Clinical staff with the appropriate licensure at our testing partners makes a work clearance determination based on the results from the testing panel.”",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/pass",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "The PASS database only stores binary yes/no ‘work clearance’ data - meaning no individual test results are uploaded to PASS. Clinical staff with the appropriate licensure at our testing partners makes a work clearance determination based on the results from the testing panel.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS database",
      "topic": "What the PASS database stores",
      "applies_to_country": "*",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "any"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_faq_outsidetest",
      "category": "Safety",
      "title": "[Unverified - being checked] PASS (Performer Availability Screening Services): Whether a producer accepts a test from any testing facility",
      "summary": "[Unverified - being checked] PASS FAQ, asked whether unregistered talent can show a producer a test from any facility, does not state an outside test is accepted; it answers that the database exists to verify work availability and that major producers have agreed to use the system to confirm the tests performers bring have not been tampered with.",
      "body": "PASS FAQ, asked whether unregistered talent can show a producer a test from any facility, does not state an outside test is accepted; it answers that the database exists to verify work availability and that major producers have agreed to use the system to confirm the tests performers bring have not been tampered with.\n\nWhat PASS / Performer Availability Screening Service, Inc. actually says:\n\n“The purpose of the PASS database is to provide verification of talent and crew’s work availability, so by participating in PASS you are showing that your records are up-to-date and that you have chosen a participating testing facility. Major adult producers have agreed to use this system in order to comply with industry standards for testing, confirm that the tests performers bring with them have not been tampered with, and for the protection of performers and crew in the event of a health safety incident.”\n\nNote: The full question is: \"What if I am talent or crew but not registered on the PASS database? Can I just show a producer a test from any testing facility?\"",
      "source_type": "official",
      "source_link": "https://www.passcertified.org/faq-1",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "PASS / Performer Availability Screening Service, Inc.",
      "evidence_quote": "The purpose of the PASS database is to provide verification of talent and crew’s work availability, so by participating in PASS you are showing that your records are up-to-date and that you have chosen a participating testing facility. Major adult producers have agreed to use this system in order to comply with industry standards for testing, confirm that the tests performers bring with them have not been tampered with, and for the protection of performers and crew in the event of a health safety incident.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS (Performer Availability Screening Services)",
      "topic": "Whether a producer accepts a test from any testing facility",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_pass_provider_minrequirements",
      "category": "Safety",
      "title": "[Unverified - being checked] Minimum requirements to become a PASS-certified provider",
      "summary": "[Unverified - being checked] FSC-PASS states the minimum requirement to become a PASS Certified provider is that the provider is a Licensed Healthcare Provider with a certified and licensed medical director and owns or contracts with a CLIA-certified laboratory, and agrees to the PASS Certification Contract and Policies and Procedures.",
      "body": "FSC-PASS states the minimum requirement to become a PASS Certified provider is that the provider is a Licensed Healthcare Provider with a certified and licensed medical director and owns or contracts with a CLIA-certified laboratory, and agrees to the PASS Certification Contract and Policies and Procedures.\n\nWhat FSC-PASS actually says:\n\n“The minimum requirement for PASS Certified providers is that they are a Licensed Healthcare Provider with a certified and licensed medical director and that they own or contract with a CLIA-certified laboratory.”\n\nNote: Same page lists CET (Cutting Edge Testing) and AIT (Adult Industry Testing) as the PASS-certified providers; no dollar prices are published there.",
      "source_type": "official",
      "source_link": "https://fscpass.com/performer-info",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "FSC-PASS",
      "evidence_quote": "The minimum requirement for PASS Certified providers is that they are a Licensed Healthcare Provider with a certified and licensed medical director and that they own or contract with a CLIA-certified laboratory.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "PASS-certified providers",
      "topic": "Minimum requirements to become a PASS-certified provider",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_calosha_bbp_condoms",
      "category": "Safety",
      "title": "[Unverified - being checked] Cal/OSHA: Condom requirement in adult film industry",
      "summary": "[Unverified - being checked] Cal/OSHA requires employers in the adult film industry to provide and ensure the use of condoms and to require use of protective barriers and administrative and work practice controls under the bloodborne pathogens standard.",
      "body": "Cal/OSHA requires employers in the adult film industry to provide and ensure the use of condoms and to require use of protective barriers and administrative and work practice controls under the bloodborne pathogens standard.\n\nWhat California Department of Industrial Relations (Cal/OSHA) actually says:\n\n“Cal/OSHA requires employers in the adult film industry to provide and ensure the use of condoms and implement other measures to protect employees from sexually transmitted infections. In observance of universal precautions under the BBP standard, employers must provide and require employees to use protective barriers and implement feasible administrative and work practice controls to prevent employees from coming into contact with blood, semen and vaginal fluids.”\n\nNote: The adult-film-specific STI rule (section 5193.1) was never adopted (separate record); section 5193 remains the operative standard per these sources.",
      "source_type": "official",
      "source_link": "https://www.dir.ca.gov/dosh/adultfilmindustry.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "California Department of Industrial Relations (Cal/OSHA)",
      "evidence_quote": "Cal/OSHA requires employers in the adult film industry to provide and ensure the use of condoms and implement other measures to protect employees from sexually transmitted infections. In observance of universal precautions under the BBP standard, employers must provide and require employees to use protective barriers and implement feasible administrative and work practice controls to prevent employees from coming into contact with blood, semen and vaginal fluids.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Cal/OSHA",
      "topic": "Condom requirement in adult film industry",
      "applies_to_country": "US",
      "applies_to_scope": "California; applies to employees, not independent contractors as stated on the page. Regulator publication dated June 20",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us-ca"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_calosha_negative_notguarantee",
      "category": "Safety",
      "title": "[Unverified - being checked] Cal/OSHA: Meaning of a negative STI test result",
      "summary": "[Unverified - being checked] Cal/OSHA states a negative test result is not a guarantee of the absence of infection, because tests often cannot detect infection in the earliest stages and can sometimes be false.",
      "body": "Cal/OSHA states a negative test result is not a guarantee of the absence of infection, because tests often cannot detect infection in the earliest stages and can sometimes be false.\n\nWhat California Department of Industrial Relations (Cal/OSHA) actually says:\n\n“However, a negative test result is not a guarantee of the absence of infection, because tests often cannot detect infection in the earliest stages. Furthermore, even in later stages, a “negative” test result can sometimes be false, such as when the person is taking antiviral or antibiotic medications.”",
      "source_type": "official",
      "source_link": "https://www.dir.ca.gov/dosh/adultfilmindustry.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "California Department of Industrial Relations (Cal/OSHA)",
      "evidence_quote": "However, a negative test result is not a guarantee of the absence of infection, because tests often cannot detect infection in the earliest stages. Furthermore, even in later stages, a “negative” test result can sometimes be false, such as when the person is taking antiviral or antibiotic medications.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Cal/OSHA",
      "topic": "Meaning of a negative STI test result",
      "applies_to_country": "US",
      "applies_to_scope": "California adult film industry guidance",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us-ca"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_calosha_exposure_followup",
      "category": "Safety",
      "title": "[Unverified - being checked] Cal/OSHA: Employer duties after an exposure incident",
      "summary": "[Unverified - being checked] Cal/OSHA states that when an exposure incident occurs the employer must offer a confidential medical evaluation to the exposed employee, have the other person's blood tested for hepatitis B, hepatitis C and HIV, and make the test results available to the exposed employee.",
      "body": "Cal/OSHA states that when an exposure incident occurs the employer must offer a confidential medical evaluation to the exposed employee, have the other person's blood tested for hepatitis B, hepatitis C and HIV, and make the test results available to the exposed employee.\n\nWhat California Department of Industrial Relations (Cal/OSHA) actually says:\n\n“When an exposure incident occurs: Offer a confidential medical evaluation to the exposed employee - Test the other person’s blood for hepatitis B, hepatitis C, and HIV, make the test results available to the exposed employee, and provide treatment and counseling to the exposed employee as required under section 5193, subsection (f)(3).”",
      "source_type": "official",
      "source_link": "https://www.dir.ca.gov/dosh/adultfilmindustry.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "California Department of Industrial Relations (Cal/OSHA)",
      "evidence_quote": "When an exposure incident occurs: Offer a confidential medical evaluation to the exposed employee - Test the other person’s blood for hepatitis B, hepatitis C, and HIV, make the test results available to the exposed employee, and provide treatment and counseling to the exposed employee as required under section 5193, subsection (f)(3).",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Cal/OSHA",
      "topic": "Employer duties after an exposure incident",
      "applies_to_country": "US",
      "applies_to_scope": "California; occupational exposure during production",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us-ca"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_calosha_5193_1_notadopted",
      "category": "Safety",
      "title": "[Unverified - being checked] Cal/OSHA: Status of the proposed adult-film STI regulation section 5193.1",
      "summary": "[Unverified - being checked] Cal/OSHA's advisory-meeting page states the Standards Board conducted rulemaking on Sexually Transmitted Infections for the adult film industry and did not vote to adopt a final proposal, instead sending it back to the Division in February 2016 to reinitiate the rulemaking with stakeholder involvement.",
      "body": "Cal/OSHA's advisory-meeting page states the Standards Board conducted rulemaking on Sexually Transmitted Infections for the adult film industry and did not vote to adopt a final proposal, instead sending it back to the Division in February 2016 to reinitiate the rulemaking with stakeholder involvement.\n\nWhat California Department of Industrial Relations (Cal/OSHA) actually says:\n\n“The Standards Board conducted the rulemaking process on Sexually Transmitted Infections (STI) and did not vote to adopt a final proposal. Instead, at its February 2016, meeting the Board voted to send the proposal back to the Division and reinitiate the rulemaking process with stakeholder involvement.”\n\nNote: Section 5193.1 existed only as advisory discussion drafts; none of the reviewed regulator pages shows a final adopted 5193.1.",
      "source_type": "official",
      "source_link": "https://www.dir.ca.gov/dosh/DoshReg/5193Meetings.htm",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "California Department of Industrial Relations (Cal/OSHA)",
      "evidence_quote": "The Standards Board conducted the rulemaking process on Sexually Transmitted Infections (STI) and did not vote to adopt a final proposal. Instead, at its February 2016, meeting the Board voted to send the proposal back to the Division and reinitiate the rulemaking process with stakeholder involvement.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Cal/OSHA",
      "topic": "Status of the proposed adult-film STI regulation section 5193.1",
      "applies_to_country": "US",
      "applies_to_scope": "California",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us-ca"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_apag_consentlist",
      "category": "Safety",
      "title": "[Unverified - being checked] APAG (Adult Performance Artists Guild): Performer consent list (The Benz List)",
      "summary": "[Unverified - being checked] APAG created a performer consent list, known as The Benz List, letting a performer state what kind of scene and which sex acts they are comfortable with prior to filming so performers understand each other's limits in advance.",
      "body": "APAG created a performer consent list, known as The Benz List, letting a performer state what kind of scene and which sex acts they are comfortable with prior to filming so performers understand each other's limits in advance.\n\nWhat APAG - Adult Performance Artists Guild actually says:\n\n“The Officers of APAG have created a performer consent list, also known as The Benz List. We have worked together to create a list that allows for a true and fair explanation of what a performer is willing to do on camera, to protect performers from having their consent violated.”",
      "source_type": "official",
      "source_link": "https://apagunion.com/performer-concerns/performer-consent-list/",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "APAG - Adult Performance Artists Guild",
      "evidence_quote": "The Officers of APAG have created a performer consent list, also known as The Benz List. We have worked together to create a list that allows for a true and fair explanation of what a performer is willing to do on camera, to protect performers from having their consent violated.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "APAG (Adult Performance Artists Guild)",
      "topic": "Performer consent list (The Benz List)",
      "applies_to_country": "*",
      "applies_to_scope": "Union/trade body publication, not a regulator.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "any"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_apag_consent_revocable",
      "category": "Safety",
      "title": "[Unverified - being checked] APAG (Adult Performance Artists Guild): Right to revoke consent",
      "summary": "[Unverified - being checked] APAG states performers have the right to revoke consent at any time.",
      "body": "APAG states performers have the right to revoke consent at any time.\n\nWhat APAG - Adult Performance Artists Guild actually says:\n\n“It is important to remember that performers have the right to revoke consent at any time.”",
      "source_type": "official",
      "source_link": "https://apagunion.com/performer-concerns/performer-consent-list/",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "APAG - Adult Performance Artists Guild",
      "evidence_quote": "It is important to remember that performers have the right to revoke consent at any time.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "APAG (Adult Performance Artists Guild)",
      "topic": "Right to revoke consent",
      "applies_to_country": "*",
      "applies_to_scope": "Union/trade body publication, not a regulator.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "any"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_fsc_moratorium_tested14days",
      "category": "Safety",
      "title": "Free Speech Coalition / PASS: 14-day testing requirement as of 2014",
      "summary": "FSC stated in 2014 that any performer who wants to work in the adult industry must test clear of STIs, including HIV, within fourteen days of their shoot date, and that regular performers generally test every two weeks at PASS-certified testing clinics.",
      "body": "FSC stated in 2014 that any performer who wants to work in the adult industry must test clear of STIs, including HIV, within fourteen days of their shoot date, and that regular performers generally test every two weeks at PASS-certified testing clinics.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“Yes. Any performer who wants to work in the adult industry must test clear of STIs, including HIV, within fourteen days of their shoot date. Performers who work regularly generally test every two weeks at PASS-certified testing clinics.”\n\nNote: Historical; consistent with current PASS 14-day window.",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/blog/blog/2014/08/28/moratorium-faqs",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "Yes. Any performer who wants to work in the adult industry must test clear of STIs, including HIV, within fourteen days of their shoot date. Performers who work regularly generally test every two weeks at PASS-certified testing clinics.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Free Speech Coalition / PASS",
      "topic": "14-day testing requirement as of 2014",
      "applies_to_country": "US",
      "applies_to_scope": "Historical statement (2014); trade body publication.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_fsc_moratorium_producers_check",
      "category": "Safety",
      "title": "[Unverified - being checked] Free Speech Coalition / PASS: Who checks the clearance document before a shoot",
      "summary": "[Unverified - being checked] FSC stated that under the PASS system producers and directors check the PASS database to confirm a performer is cleared within the past fourteen days, and a performer without a recent test or with any irregularity will not be cleared to perform.",
      "body": "FSC stated that under the PASS system producers and directors check the PASS database to confirm a performer is cleared within the past fourteen days, and a performer without a recent test or with any irregularity will not be cleared to perform.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“Under the PASS system, producers and directors check to confirm that the performer is cleared to perform in the PASS database within the past fourteen days. If a performer does not have a recent test, or shows any irregularity, he or she will not be cleared to perform.”\n\nNote: FSC's current PASS pages also instruct that clearance should be checked online \"and never through a printed paper or screenshot\".",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/blog/blog/2014/08/28/moratorium-faqs",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "Under the PASS system, producers and directors check to confirm that the performer is cleared to perform in the PASS database within the past fourteen days. If a performer does not have a recent test, or shows any irregularity, he or she will not be cleared to perform.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Free Speech Coalition / PASS",
      "topic": "Who checks the clearance document before a shoot",
      "applies_to_country": "US",
      "applies_to_scope": "Historical statement (2014); trade body publication.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_fsc_moratorium_partners",
      "category": "Safety",
      "title": "[Unverified - being checked] Free Speech Coalition / PASS: Co-performer notification after a positive HIV result",
      "summary": "[Unverified - being checked] FSC stated that when an active performer tests positive for HIV the PASS doctors and FSC work to ensure that any performers the positive person had sexual contact with off-set, and any other individuals of concern, are informed and tested.",
      "body": "FSC stated that when an active performer tests positive for HIV the PASS doctors and FSC work to ensure that any performers the positive person had sexual contact with off-set, and any other individuals of concern, are informed and tested.\n\nWhat Free Speech Coalition (FSC) actually says:\n\n“If the performer had sexual contact with other performers off-set, the PASS doctors and FSC will work to make sure those people are informed and tested as well as any other individuals with which the performer had sexual contact.”\n\nNote: No tier-A statement describing routine pre-shoot test-result disclosure between co-performers was found; see could_not_verify.",
      "source_type": "official",
      "source_link": "https://www.freespeechcoalition.com/blog/blog/2014/08/28/moratorium-faqs",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Free Speech Coalition (FSC)",
      "evidence_quote": "If the performer had sexual contact with other performers off-set, the PASS doctors and FSC will work to make sure those people are informed and tested as well as any other individuals with which the performer had sexual contact.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Free Speech Coalition / PASS",
      "topic": "Co-performer notification after a positive HIV result",
      "applies_to_country": "US",
      "applies_to_scope": "Occurs in the context of a positive HIV result and a production moratorium.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_hiv_nat_window",
      "category": "Safety",
      "title": "[Unverified - being checked] CDC - HIV: Window period for nucleic acid test (NAT)",
      "summary": "[Unverified - being checked] CDC states a NAT can usually detect HIV 10 to 33 days after exposure.",
      "body": "CDC states a NAT can usually detect HIV 10 to 33 days after exposure.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“A NAT can usually detect HIV 10 to 33 days after exposure.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/hiv/testing/index.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "A NAT can usually detect HIV 10 to 33 days after exposure.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - HIV",
      "topic": "Window period for nucleic acid test (NAT)",
      "applies_to_country": "US",
      "applies_to_scope": "PASS panel requires an HIV-1 RNA PCR (a NAT-type test) plus a 4th-gen antigen/antibody test.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_hiv_agab_window",
      "category": "Safety",
      "title": "[Unverified - being checked] CDC - HIV: Window period for antigen/antibody lab test",
      "summary": "[Unverified - being checked] CDC states an antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure.",
      "body": "CDC states an antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/hiv/testing/index.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - HIV",
      "topic": "Window period for antigen/antibody lab test",
      "applies_to_country": "US",
      "applies_to_scope": "PASS panel requires an HIV 1/2 4th-gen AB/AG test.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "failed",
        "label": "Unverified - being checked",
        "reasons": [
          "hollow_body",
          "quote_is_nonanswer",
          "strong_label_on_weak_content"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_gonorrhea_retest",
      "category": "Safety",
      "title": "[Unverified - being checked] Retesting interval after gonorrhea treatment",
      "summary": "[Unverified - being checked] CDC states those with gonorrhea should be retested about three months after treatment of an initial infection, and should wait seven days after finishing all medicine before having sex.",
      "body": "CDC states those with gonorrhea should be retested about three months after treatment of an initial infection, and should wait seven days after finishing all medicine before having sex.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“Those with gonorrhea should be retested about three months after treatment of an initial infection, even if their partners received successful treatment. Wait seven days after finishing all medicine before having sex.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea.htm",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "Those with gonorrhea should be retested about three months after treatment of an initial infection, even if their partners received successful treatment. Wait seven days after finishing all medicine before having sex.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Gonorrhea",
      "topic": "Retesting interval after gonorrhea treatment",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_chlamydia_retest",
      "category": "Safety",
      "title": "[Unverified - being checked] Retesting interval after chlamydia treatment",
      "summary": "[Unverified - being checked] CDC states you should receive testing again about three months after chlamydia treatment, and if given a single dose of medicine to wait seven days after taking it before sex.",
      "body": "CDC states you should receive testing again about three months after chlamydia treatment, and if given a single dose of medicine to wait seven days after taking it before sex.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“You should receive testing again about three months after your treatment, even if your sex partner(s) receives treatment. If given a single dose of medicine, you should wait seven days after taking the medicine before having sex.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "You should receive testing again about three months after your treatment, even if your sex partner(s) receives treatment. If given a single dose of medicine, you should wait seven days after taking the medicine before having sex.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Chlamydia",
      "topic": "Retesting interval after chlamydia treatment",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_hepb_screening",
      "category": "Safety",
      "title": "[Unverified - being checked] Screening interval for hepatitis B",
      "summary": "[Unverified - being checked] CDC recommends all adults get screened for hepatitis B at least once in their lifetime through a blood test, with more frequent testing for people with ongoing risk for exposures.",
      "body": "CDC recommends all adults get screened for hepatitis B at least once in their lifetime through a blood test, with more frequent testing for people with ongoing risk for exposures.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“CDC recommends all adults get screened for hepatitis B at least once in their lifetime through a blood test. There are also some people who should be tested more often, including: All pregnant women during each pregnancy. Infants born to pregnant women with HBV infection. People with ongoing risk for exposures.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/hepatitis-b/about/index.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "CDC recommends all adults get screened for hepatitis B at least once in their lifetime through a blood test. There are also some people who should be tested more often, including: All pregnant women during each pregnancy. Infants born to pregnant women with HBV infection. People with ongoing risk for exposures.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Hepatitis B",
      "topic": "Screening interval for hepatitis B",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_hepc_testing",
      "category": "Safety",
      "title": "[Unverified - being checked] Testing recommendation for hepatitis C",
      "summary": "[Unverified - being checked] CDC recommends hepatitis C testing for all adults, all pregnant women, and anyone who may have been recently exposed, and states symptoms, if they develop, appear 2-12 weeks after infection.",
      "body": "CDC recommends hepatitis C testing for all adults, all pregnant women, and anyone who may have been recently exposed, and states symptoms, if they develop, appear 2-12 weeks after infection.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“CDC recommends hepatitis C testing for all adults, all pregnant women, and for anyone who may have been recently exposed. If you do develop symptoms, you will notice them 2-12 weeks after infection with the virus.”",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/hepatitis-c/about/index.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "CDC recommends hepatitis C testing for all adults, all pregnant women, and for anyone who may have been recently exposed. If you do develop symptoms, you will notice them 2-12 weeks after infection with the virus.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Hepatitis C",
      "topic": "Testing recommendation for hepatitis C",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_trich_retest",
      "category": "Safety",
      "title": "[Unverified - being checked] Retesting interval after trichomoniasis treatment",
      "summary": "[Unverified - being checked] CDC states you should receive testing again about three months after trichomoniasis treatment, and that some people get symptoms within 5 to 28 days after getting the infection.",
      "body": "CDC states you should receive testing again about three months after trichomoniasis treatment, and that some people get symptoms within 5 to 28 days after getting the infection.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“You should receive testing again about three months after your treatment, even if your sex partner(s) received treatment. Some people get symptoms within 5 to 28 days after getting the infection.”\n\nNote: The CDC does not publish a laboratory detection window period for trichomoniasis on the page opened; only symptom onset is stated.",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/trichomoniasis/about/index.html",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "You should receive testing again about three months after your treatment, even if your sex partner(s) received treatment. Some people get symptoms within 5 to 28 days after getting the infection.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Trichomoniasis",
      "topic": "Retesting interval after trichomoniasis treatment",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_cdc_syphilis_diagnosis",
      "category": "Safety",
      "title": "[Unverified - being checked] How syphilis is diagnosed",
      "summary": "[Unverified - being checked] CDC states that most of the time healthcare providers use a blood test to test for syphilis, and some diagnose syphilis by testing fluid from a syphilis sore.",
      "body": "CDC states that most of the time healthcare providers use a blood test to test for syphilis, and some diagnose syphilis by testing fluid from a syphilis sore.\n\nWhat US Centers for Disease Control and Prevention (CDC) actually says:\n\n“Most of the time, healthcare providers will use a blood test to test for syphilis. Some will diagnose syphilis by testing fluid from a syphilis sore.”\n\nNote: The opened CDC page states syphilis is curable with antibiotics but does not publish a window period for syphilis testing; see could_not_verify.",
      "source_type": "official",
      "source_link": "https://www.cdc.gov/std/syphilis/stdfact-syphilis.htm",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "US Centers for Disease Control and Prevention (CDC)",
      "evidence_quote": "Most of the time, healthcare providers will use a blood test to test for syphilis. Some will diagnose syphilis by testing fluid from a syphilis sore.",
      "volatility": "low",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "CDC - Syphilis",
      "topic": "How syphilis is diagnosed",
      "applies_to_country": "US",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_tts_gsp_price",
      "category": "Safety",
      "title": "[Unverified - being checked] Talent Testing Service (TTS): Price and contents of the performer Gold Standard Panel",
      "summary": "[Unverified - being checked] Talent Testing Service - an independent industry testing service that markets a panel to performers - lists a Gold Standard Panel (GSP) at $155.00 covering HIV-1 NAT, HIV Ag/Ab, HBsAg, Anti-HCV, Chlamydia and Gonorrhea (urine), Trichomonas Vaginalis, Syphilis (RPR) and Treponema pallidum Antibody.",
      "body": "Talent Testing Service - an independent industry testing service that markets a panel to performers - lists a Gold Standard Panel (GSP) at $155.00 covering HIV-1 NAT, HIV Ag/Ab, HBsAg, Anti-HCV, Chlamydia and Gonorrhea (urine), Trichomonas Vaginalis, Syphilis (RPR) and Treponema pallidum Antibody.\n\nWhat Talent Testing Service, Inc. actually says:\n\n“Gold Standard Panel (GSP) $155.00 - HIV-1 NAT - HIV Ag/Ab - HBsAg - Anti-HCV - Chlamydia (Urine) - Gonorrhea (Urine) - Trichomonas Vaginalis - Syphilis (RPR) - Treponema pallidum Antibody”\n\nNote: Marketplace provider, not a regulator; use for cost reference only. Same page lists a TTS Unlimited Pass at $460.00 per month with unlimited testing including GSP, standalone CT/GC throat and rectal swabs, and Mycoplasma genitalium.",
      "source_type": "official",
      "source_link": "https://talenttestingservice.com/tests.asp",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Talent Testing Service, Inc.",
      "evidence_quote": "Gold Standard Panel (GSP) $155.00 - HIV-1 NAT - HIV Ag/Ab - HBsAg - Anti-HCV - Chlamydia (Urine) - Gonorrhea (Urine) - Trichomonas Vaginalis - Syphilis (RPR) - Treponema pallidum Antibody",
      "volatility": "high",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Talent Testing Service (TTS)",
      "topic": "Price and contents of the performer Gold Standard Panel",
      "applies_to_country": "US",
      "applies_to_scope": "Independent commercial laboratory service; its own fee page. Not listed among PASS-certified providers on the fscpass.co",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_tts_validity",
      "category": "Safety",
      "title": "[Unverified - being checked] TTS validity periods for its performer panel",
      "summary": "[Unverified - being checked] TTS states its Gold Standard Panel is valid for 30 days and that it indicates expiration dates for 7, 14, and 30 days after the date of collection, with producers able to request a test performed within the last 7, 14 or 30 days.",
      "body": "TTS states its Gold Standard Panel is valid for 30 days and that it indicates expiration dates for 7, 14, and 30 days after the date of collection, with producers able to request a test performed within the last 7, 14 or 30 days.\n\nWhat Talent Testing Service, Inc. actually says:\n\n“The Gold Standard Panel (GSP) is valid for 30 days. However, we also indicate expiration dates for 7, 14, and 30 days after the date of collection. Depending on who you are working with, you may be requested to present a current test that was performed within the last 7, 14, or 30 days.”",
      "source_type": "official",
      "source_link": "https://talenttestingservice.com/faq.asp",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Talent Testing Service, Inc.",
      "evidence_quote": "The Gold Standard Panel (GSP) is valid for 30 days. However, we also indicate expiration dates for 7, 14, and 30 days after the date of collection. Depending on who you are working with, you may be requested to present a current test that was performed within the last 7, 14, or 30 days.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Talent Testing Service (TTS)",
      "topic": "TTS validity periods for its performer panel",
      "applies_to_country": "US",
      "applies_to_scope": "Independent service; validity is its own product rule, not the PASS standard.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "thin_body",
          "source_unverifiable:fetch_failed:budget"
        ],
        "checked_utc": "20261021-123916Z"
      }
    },
    {
      "id": "learn_r157_sti_testing_and_co_performer_standard_tts_turnaround",
      "category": "Safety",
      "title": "[Unverified - being checked] TTS result turnaround times",
      "summary": "[Unverified - being checked] TTS states it offers same-day results at its Miami office if a performer tests before noon and next-day (9:00 am) results for its Los Angeles and Las Vegas tests, and that results are reported within one business day barring out-of-the-ordinary events.",
      "body": "TTS states it offers same-day results at its Miami office if a performer tests before noon and next-day (9:00 am) results for its Los Angeles and Las Vegas tests, and that results are reported within one business day barring out-of-the-ordinary events.\n\nWhat Talent Testing Service, Inc. actually says:\n\n“Same day results at Miami office, if you test before noon. 9:00 am next day results for our LA, and LV tests. Results will be reported within one business day after collected at the estimated times listed above as long as no out-of the-ordinary events are experienced.”\n\nNote: PASS's own standard is that results are typically expected within 48 hours (separate record); TTS publishes faster desk comments.",
      "source_type": "official",
      "source_link": "https://talenttestingservice.com/default.asp",
      "last_verified": "2026-09-07",
      "reliability": "STRONG PRACTICE",
      "source_tier": "A",
      "source_publisher": "Talent Testing Service, Inc.",
      "evidence_quote": "Same day results at Miami office, if you test before noon. 9:00 am next day results for our LA, and LV tests. Results will be reported within one business day after collected at the estimated times listed above as long as no out-of the-ordinary events are experienced.",
      "volatility": "medium",
      "from_batch": "157-sti-testing-and-co-performer-standard",
      "subject": "Talent Testing Service (TTS)",
      "topic": "TTS result turnaround times",
      "applies_to_country": "US",
      "applies_to_scope": "Independent service; its own published schedule.",
      "tags": {
        "lane": "any",
        "stage": "any",
        "region": [
          "us"
        ],
        "platform": "any",
        "topic": [
          "unclassified"
        ],
        "explicitness": "any"
      },
      "verification": {
        "status": "unverified",
        "label": "Unverified - being checked",
        "reasons": [
          "legal_fetch_over_cap"
        ],
        "checked_utc": "20261021-123916Z"
      }
    }
  ]
}
